Realised that I had actually forgotten to do an update for the month of January as I was busy preparing for Chinese New Year in the early part of February.
This year did not start off very well and we had seen a major sell-off in the month of January with China’s major stock exchanges triggering “circuit breakers” consecutively and the Dow Jones Industrial Average plunging 9.52% from the last trading day of 2015 till mid-January 2016.
In February, we have seen a partial recovery of the stock index and it looks like the investors are coming back, picking discounted stocks to add into their portfolio.
For the month of January, I had received $3.18 worth of dividends from Automatic Data Processing, Inc. (NASDAQ: ADP) while Clorox Co (NYSE: CLX) and Abott Laboratories (NYSE: ABT) paid their dividends of $6.16 and $5.72 respectively in February.
Total year-to-date (YTD) dividends, as of February 29, is $15.06 or 0.26%, inclusive of the dividends that were reinvested.
All the dividends were reinvested.
|Home Depot, Inc.||HD||$0.00||0.00%|
|Johnson & Johnson||JNJ||$0.00||0.00%|
|Automatic Data Processing, Inc.||ADP||$3.18||0.35%|
|Home Depot, Inc.||HD||8.00||$1,008.67|
|Johnson & Johnson||JNJ||9.00||$917.68|
|Automatic Data Processing, Inc.||ADP||11.027||$904.19|
|Total Investment Amount||$5,768.69|
Profit & Loss
Most of the stocks within my portfolio managed to recover and entered into the profit zones with the exceptions of Home Depot, Inc. (NYSE: HD) and Abott Laboratories (NYSE: ABT). Overall health status of the portfolio looks healthy.
|Home Depot, Inc.||HD||$15.71||1.56%|
|Johnson & Johnson||JNJ||$27.86||3.04%|
|Automatic Data Processing, Inc.||ADP||$29.68||3.28%
Although Abbott Laboratories had fallen 13.4% from my average purchase price, the stock price is mainly affected by the unfavourable exchange rate, lowering their earnings. I will continue to monitor the situation and decide if there is a need to readjust the portfolio.
Johnson & Johnson (NYSE: JNJ) had recently also made headlines when they admitted to some of their products contains cancer causing ingredients. However, JNJ had cited that they had used minimal amounts of the ingredients. Although the admitting of the use of cancer causing ingredients will not do good on the company outlook, I will continue to hold on my portfolio and judge if there will be a need to invest the money into another company.